| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 03/12/2003 | EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1402730A Thiazolo (4,5-D) pyrimidine compounds |
| 03/12/2003 | CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 03/12/2003 | CN1401634A 4-guanidinobenzamides antifertility compounds |
| 03/11/2003 | US6531612 Nitrile derivatives that inhibit cathepsin K |
| 03/11/2003 | US6531610 Intermediate acylating carbonate |
| 03/11/2003 | US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. |
| 03/11/2003 | US6531485 Prostaglandin agonists |
| 03/11/2003 | US6531479 Anti-cancer compounds |
| 03/11/2003 | US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have |
| 03/10/2003 | CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 03/06/2003 | WO2003018571A1 M-aminophenol derivatives and colouring agents containing them |
| 03/06/2003 | WO2003018553A1 Oral antidiabetic agents |
| 03/06/2003 | WO2003018535A2 Novel aminobenzoephenones |
| 03/06/2003 | WO2003018515A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 03/06/2003 | WO2003018135A1 Method of using 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| 03/06/2003 | WO2003018011A1 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| 03/06/2003 | WO2003018010A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity |
| 03/06/2003 | WO2003018008A1 Apo ai expression accelerating agent |
| 03/06/2003 | WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 03/06/2003 | WO2003017764A1 Substituted propargylamines |
| 03/06/2003 | WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/06/2003 | WO2002099097A8 Novel compounds for chemiluminescense procedures |
| 03/06/2003 | WO2002094770A3 Aminoalcohol derivatives |
| 03/06/2003 | US20030045755 Polyamine analogues as cytotoxic agents |
| 03/06/2003 | US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/06/2003 | US20030045558 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides) |
| 03/06/2003 | US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents |
| 03/06/2003 | CA2458681A1 M-aminophenol derivatives and colouring agents containing them |
| 03/06/2003 | CA2458621A1 Oral antidiabetic agents |
| 03/06/2003 | CA2457836A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity |
| 03/06/2003 | CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 03/06/2003 | CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 03/05/2003 | EP1288207A1 Process for the preparation of 4,5-dihydro-1,3-thiazoles |
| 03/05/2003 | EP1287018A2 Thrombin inhibitors |
| 03/05/2003 | EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286976A1 Method for producing 2-chloro-5-chloromethyl-1,3-thiazole |
| 03/05/2003 | EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 03/05/2003 | EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1286670A2 Use of therapeutic benzamide derivatives |
| 03/05/2003 | EP0939628B1 Thiol sulfone metalloprotease inhibitors |
| 03/05/2003 | EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/05/2003 | CN1400899A Use of 2-methyl thiazolidin-2, 4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
| 03/05/2003 | CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives |
| 03/05/2003 | CN1102595C Penems and their derivatives |
| 03/05/2003 | CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound |
| 03/05/2003 | CN1102583C Cationic polypeptide condensing agent of thiazole,its synthesizing process and its application |
| 03/05/2003 | CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same |
| 03/04/2003 | US6528652 Composition and device for detecting leukocytes in urine |
| 03/04/2003 | US6528651 Ring cleavage deamination of a triazacylclohexane derivative with hydrogen chloride |
| 03/04/2003 | US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea |
| 03/04/2003 | US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N |
| 03/04/2003 | US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 03/04/2003 | US6528525 Amidocarboxylic acid derivatives |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 02/28/2003 | CA2399927A1 Process for preparing 4,5-dihydro-1,3-thiazoles |
| 02/27/2003 | WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ |
| 02/27/2003 | WO2003016288A1 Fxr nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003016280A1 Nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003016270A2 Selective estrogen receptor modulators |
| 02/27/2003 | WO2003016266A1 β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF |
| 02/27/2003 | WO2003016265A1 Cyclic compound and ppar agonist |
| 02/27/2003 | WO2003015778A1 Tyrosine kinase inhibitors |
| 02/27/2003 | WO2003015777A1 Nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/27/2003 | WO2003015775A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 02/27/2003 | WO2003015774A1 Compounds effecting glucokinase |
| 02/27/2003 | WO2003015773A2 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
| 02/27/2003 | WO2003015772A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | WO2003015717A2 Tyrosine kinase inhibitors |
| 02/27/2003 | WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002060374A3 Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040525 Inhibition of human telomerase by a G-quadruplex-interaction compound |
| 02/27/2003 | CA2456868A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | CA2423025A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 02/26/2003 | EP1285914A1 Nr1h4 nuclear receptor binding compounds |
| 02/26/2003 | EP1285911A2 Arylsulfonanilide ureas |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use |
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/25/2003 | US6525220 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 02/25/2003 | US6525211 Herbicidal sulphonylamino(thio)carbonyl compounds |
| 02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
| 02/25/2003 | US6525080 Thiazoline acid derivatives |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/20/2003 | WO2003014096A1 Process of production of n-alkyl-2-benzthiazolylsulfeneimides, device for their production and method of their purification |
| 02/20/2003 | WO2003014095A1 Acylaminothiazole derivatives, their preparation and therapeutic use |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | WO2003013520A1 Pramipexole for the treatment of adhd |
| 02/20/2003 | WO2003013519A1 Pramipexol as an anticonvulsive agent |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor. |
| 02/20/2003 | US20030036532 Treatment of infections caused by parasites, especially malaria. |